{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T09:02:54Z","timestamp":1784710974049,"version":"3.55.0"},"reference-count":49,"publisher":"European Respiratory Society (ERS)","issue":"181","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir Rev"],"accepted":{"date-parts":[[2026,5,8]]},"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Obese children with asthma experience higher morbidity than their counterparts; whether different treatments should be considered remains to be clarified.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To explore the potential group differences in the treatment response to any asthma medications between overweight\/obese and normal\/underweight children.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We systematically reviewed case\u2013control, cohort studies and randomised controlled trials (RCTs) examining treatment effects by weight status, identified in four bibliographic databases from inception until January 2025. A narrative synthesis was presented because a meta-analysis could not be conducted due to methodological issues.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Nine studies (one RCT, five\n                      <jats:italic>post hoc<\/jats:italic>\n                      analyses of RCTs, two cohorts, and one\n                      <jats:italic>post hoc<\/jats:italic>\n                      analysis of a case\u2013control study), including 7089 children (33.9% overweight\/obese), met the inclusion criteria. Pharmacological treatment pertained to step 1\u20132 (n=1), step 2 (n=3), step 3 (n=2), step 5 (n=2), and bronchodilator-response (n=1). Compared with normal weight, step 1\u20132 showed a trend toward reduced inhaled corticosteroid (ICS) efficiency in minimising symptom days in overweight\/obese preschoolers. Regarding step 2 monotherapy, overweight\/obese children may benefit as much (or more) from nedocromil or leukotriene receptor antagonist (LTRA) than from ICS. In step 3, adding LTRA (\n                      <jats:italic>versus<\/jats:italic>\n                      placebo) to ICS monotherapy was more effective, whereas higher-dose ICS monotherapy was less effective than LTRA or long-acting \u03b2\n                      <jats:sub>2<\/jats:sub>\n                      -agonist (LABA) combination therapy in obese than normal-weight children; adding LABA appears equally effective across weight groups. A similar or better response to omalizumab was observed in obese compared to nonobese children.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>While no firm recommendations could be made regarding potential differential treatment responses, the superiority of ICS monotherapy or step-up therapy compared to other controllers appears lost in overweight\/obese children.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1183\/16000617.0311-2025","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T08:30:20Z","timestamp":1784709020000},"page":"250311","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative response to pharmacological management of asthma in overweight\/obese children\n                    <i>versus<\/i>\n                    their counterparts: a systematic review and call for data"],"prefix":"10.1183","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0708-4281","authenticated-orcid":false,"given":"Jose A.","family":"Castro-Rodriguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2659-7576","authenticated-orcid":false,"given":"Samantha H.","family":"Averill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1746-466X","authenticated-orcid":false,"given":"M. Isabel","family":"Castro-Guevara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5096-0614","authenticated-orcid":false,"given":"Francine M.","family":"Ducharme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"2026072201301151000_35.181.250311.1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02866-2021"},{"key":"2026072201301151000_35.181.250311.2","unstructured":"Centers for Disease Control and Prevention (CDC) . Most Recent National Asthma Data. 2021. Date last accessed: 5 March 2025. Date last updated: 10 May 2023. www.cdc.gov\/asthma\/most_recent_national_asthma_data.htm"},{"key":"2026072201301151000_35.181.250311.3","unstructured":"World Health Organization (WHO) . Obesity and Overweight. Date last accessed: 5 March 2025. Date last updated: 8 December 2025. www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight#:\u223c:text=In%202022%2C%2043%25%20of%20adults,who%20were%20living%20with%20obesity"},{"key":"2026072201301151000_35.181.250311.4","unstructured":"Centers for Disease Control and Prevention (CDC) . Childhood Obesity Facts. Date last accessed: 5 March 2025. Date last updated: 6 May 2026. www.cdc.gov\/obesity\/childhood-obesity-facts\/childhood-obesity-facts.html"},{"key":"2026072201301151000_35.181.250311.5","doi-asserted-by":"crossref","first-page":"e12532","DOI":"10.1111\/ijpo.12532","article-title":"Association between overweight or obesity and the risk for childhood asthma and wheeze: an updated meta-analysis on 18 articles and 73 252 children","volume":"14","author":"Deng","year":"2019","journal-title":"Pediatr Obes"},{"key":"2026072201301151000_35.181.250311.6","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13129"},{"key":"2026072201301151000_35.181.250311.7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-789X.2012.01055.x"},{"key":"2026072201301151000_35.181.250311.8","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-2119"},{"key":"2026072201301151000_35.181.250311.9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/cea.13534","article-title":"Pubertal BMI change and adult-onset asthma in men: population-based cohort study in Sweden","volume":"50","author":"Nwaru","year":"2020","journal-title":"Clin Exp Allergy"},{"key":"2026072201301151000_35.181.250311.10","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S2352-4642(22)00185-7","article-title":"Obesity-related asthma in children and adolescents","volume":"6","author":"Reyes-Angel","year":"2022","journal-title":"Lancet Child Adolesc Health"},{"key":"2026072201301151000_35.181.250311.11","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/ppul.24600","article-title":"Pediatric obesity-related asthma: a prototype of pediatric severe non-T2 asthma","volume":"55","author":"Rastogi","year":"2020","journal-title":"Pediatr Pulmonol"},{"key":"2026072201301151000_35.181.250311.12","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00766-2016"},{"key":"2026072201301151000_35.181.250311.13","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/ppe.12760","article-title":"Childhood patterns of overweight and wheeze and subsequent risk of current asthma and obesity in adolescence","volume":"35","author":"Aris","year":"2021","journal-title":"Paediatr Perinat Epidemiol"},{"key":"2026072201301151000_35.181.250311.14","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/EDE.0000000000001421","article-title":"The role of childhood asthma in obesity development: a nationwide US multicohort study","volume":"33","author":"Stratakis","year":"2022","journal-title":"Epidemiology"},{"key":"2026072201301151000_35.181.250311.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.12.010"},{"key":"2026072201301151000_35.181.250311.16","unstructured":"Global Initiative for Asthma (GINA) . Global Strategy for Asthma Management and Prevention. 2024. Date last updated: May 2024. www.ginasthma.org"},{"key":"2026072201301151000_35.181.250311.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.10.003"},{"key":"2026072201301151000_35.181.250311.18","unstructured":"British Thoracic Society (BTS) , National Institute for Health and Care Excellence (NICE) , Sottish Intercollegiate Guidelines (SIGN) . Asthma: Diagnosis, Monitoring and Chronic Asthma Management (SIGN 245). Revised edition November 2024. www.sign.ac.uk\/our-guidelines\/asthma-diagnosis-monitoring-and-chronic-asthma-management\/"},{"key":"2026072201301151000_35.181.250311.19","first-page":"348","article-title":"Canadian Thoracic Society 2021 guideline update: diagnosis and management of asthma in preschoolers, children and adults","volume":"5","author":"Yang","year":"2021","journal-title":"Can J Respir Crit Care Sleep Med"},{"key":"2026072201301151000_35.181.250311.20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097"},{"key":"2026072201301151000_35.181.250311.21","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4919"},{"key":"2026072201301151000_35.181.250311.22","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898"},{"key":"2026072201301151000_35.181.250311.23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1513\/AnnalsATS.201702-101OC","article-title":"Discovering pediatric asthma phenotypes on the basis of response to controller medication using machine learning","volume":"15","author":"Ross","year":"2018","journal-title":"Ann Am Thorac Soc"},{"key":"2026072201301151000_35.181.250311.24","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2019-000401"},{"key":"2026072201301151000_35.181.250311.25","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.anai.2017.05.024","article-title":"Effectiveness of montelukast in overweight and obese atopic asthmatics","volume":"119","author":"Farzan","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2026072201301151000_35.181.250311.26","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.jaci.2017.10.052","article-title":"The obese-asthma phenotype in children: an exacerbating situation?","volume":"141","author":"Longo","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"2026072201301151000_35.181.250311.27","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jaip.2013.01.011","article-title":"Reassessment of omalizumab-dosing strategies and pharmacodynamics in inner-city children and adolescents","volume":"1","author":"Sorkness","year":"2013","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026072201301151000_35.181.250311.28","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1016\/j.jaip.2020.03.033","article-title":"Treatment benefit with omalizumab in children by indicators of asthma severity","volume":"8","author":"Szefler","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026072201301151000_35.181.250311.29","doi-asserted-by":"publisher","DOI":"10.1378\/chest.14-2689"},{"key":"2026072201301151000_35.181.250311.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.09.043"},{"key":"2026072201301151000_35.181.250311.31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12916-025-03847-z","article-title":"Regular versus as-needed treatments for mild asthma in children, adolescents, and adults: a systematic review and network meta-analysis","volume":"23","author":"Pornsuriyasak","year":"2025","journal-title":"BMC Med"},{"key":"2026072201301151000_35.181.250311.32","unstructured":"U.S. Food and Drug Administration (FDA) . FDA Requires Boxed Warning About Serious Mental Health Side Effects for Asthma and Allergy Drug Montelukast (Singulair); Advises Restricting Use for Allergic Rhinitis. 3-4-2020 FDA Drug Safety Communication. 2020. Date last updated: 13 March 2020. Date last accessed: March 2025. www.fda.gov\/drugs\/drug-safety-and-availability\/fda-requires-boxed-warning-about-serious-mental-health-side-effects-asthma-and-allergy-drug."},{"key":"2026072201301151000_35.181.250311.33","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.06.00077205"},{"key":"2026072201301151000_35.181.250311.34","doi-asserted-by":"publisher","DOI":"10.2500\/aap.2010.31.3307"},{"key":"2026072201301151000_35.181.250311.35","doi-asserted-by":"publisher","DOI":"10.3109\/02770900903338494"},{"key":"2026072201301151000_35.181.250311.36","doi-asserted-by":"crossref","first-page":"744782","DOI":"10.3389\/fimmu.2021.744782","article-title":"Dexamethasone-induced FKBP51 expression in CD4+ T-lymphocytes is uniquely associated with worse asthma control in obese children with asthma","volume":"12","author":"Tejwani","year":"2021","journal-title":"Front Immunol"},{"key":"2026072201301151000_35.181.250311.37","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200801-076OC"},{"key":"2026072201301151000_35.181.250311.38","doi-asserted-by":"crossref","first-page":"6844","DOI":"10.1038\/s41598-025-88423-4","article-title":"Single-cell analysis identifies distinct CD4+\u2009T cells associated with the pathobiology of pediatric obesity related asthma","volume":"15","author":"Thompson","year":"2025","journal-title":"Sci Rep"},{"key":"2026072201301151000_35.181.250311.39","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00363.2001"},{"key":"2026072201301151000_35.181.250311.40","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.3389\/fimmu.2020.01724","article-title":"Contribution of IL-17 in steroid hyporesponsiveness in obese asthmatics through dysregulation of glucocorticoid receptors \u03b1 and \u03b2","volume":"11","author":"Al Heialy","year":"2020","journal-title":"Front Immunol"},{"key":"2026072201301151000_35.181.250311.41","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1080\/02770903.2019.1590593","article-title":"Weight status and nonadherence to asthma maintenance therapy among children enrolled in a public drug insurance plan","volume":"57","author":"Longo","year":"2020","journal-title":"J Asthma"},{"key":"2026072201301151000_35.181.250311.42","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/ppul.25253","article-title":"Nonadherence to inhaled corticosteroids: a characteristic of the pediatric obese-asthma phenotype?","volume":"56","author":"Orri\u00ebns","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"2026072201301151000_35.181.250311.43","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.anai.2023.10.001","article-title":"Management of the pediatric patient with asthma and obesity","volume":"132","author":"Averill","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2026072201301151000_35.181.250311.44","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1164\/rccm.202406-1166SO","article-title":"Obesity-related asthma: a pathobiology-based overview of existing and emerging treatment approaches","volume":"210","author":"Althoff","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"2026072201301151000_35.181.250311.45","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.58.12.1036"},{"key":"2026072201301151000_35.181.250311.46","doi-asserted-by":"crossref","first-page":"107375","DOI":"10.1016\/j.rmed.2023.107375","article-title":"Bronchodilator response does not associate with asthma control or symptom burden among patients with poorly controlled asthma","volume":"218","author":"Kaminsky","year":"2023","journal-title":"Respir Med"},{"key":"2026072201301151000_35.181.250311.47","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1164\/rccm.202112-2745OC","article-title":"The impact of insulin resistance on loss of lung function and response to treatment in asthma","volume":"206","author":"Peters","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"2026072201301151000_35.181.250311.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.01.036"},{"key":"2026072201301151000_35.181.250311.49","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2016.08.16"}],"container-title":["European Respiratory Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/16000617.0311-2025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T08:30:31Z","timestamp":1784709031000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/16000617.0311-2025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":49,"journal-issue":{"issue":"181","published-online":{"date-parts":[[2026,7,22]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1183\/16000617.0311-2025"],"URL":"https:\/\/doi.org\/10.1183\/16000617.0311-2025","relation":{},"ISSN":["0905-9180","1600-0617"],"issn-type":[{"value":"0905-9180","type":"print"},{"value":"1600-0617","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]}}}